Current status of biosimilars in Turkey: A survey among medical oncologists.
J Oncol Pharm Pract
; 28(7): 1516-1523, 2022 Oct.
Article
in En
| MEDLINE
| ID: mdl-34313505
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Biosimilar Pharmaceuticals
/
Oncologists
Limits:
Humans
Country/Region as subject:
Asia
Language:
En
Journal:
J Oncol Pharm Pract
Journal subject:
FARMACIA
Year:
2022
Type:
Article
Affiliation country:
Turkey